Carboplatin and Paclitaxel as Therapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
Read Dr Love's original email (from July 30, 2010) | Subscribe to Dr Love's email alerts |
Quoix EA et al. Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC). Proc ASCO 2010;Abstract 7509.